Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meibomian Gland Dysfunction Management With Zocular Eyelid System Treatment (ZEST) to Relieve Contact Lens Discomfort

NCT03968731 is registered in ClinicalTrials.gov with University of the Incarnate Word as lead sponsor.

NCT NCT03968731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03968731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meibomian Gland Dysfunction Management With Zocular Eyelid System Treatment (ZEST) to Relieve Contact Lens Discomfort
Lead sponsor
University of the Incarnate Word
Phase
Not applicable
Overall status
Completed
Start date
June 10, 2019
Completion date
May 31, 2020
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes, meibomian gland dysfunction, ocular surface disease